tiprankstipranks
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market
BNTX
BioNTech SE
RESEARCH TOOLSreports

BioNTech SE (BNTX) Financial Statements

Compare
4,833 Followers

BioNTech SE Financial Overview

BioNTech SE's market cap is currently $22.31B. The company's EPS TTM is $-1.4427024999999998; its P/E ratio is ―; BioNTech SE is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $-2.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 2.76B€ 2.75B€ 3.82B€ 17.31B€ 18.98B
Gross Profit€ 2.14B€ 2.21B€ 3.22B€ 14.32B€ 16.07B
Operating Income€ -623.87M€ -1.31B€ 690.40M€ 12.64B€ 15.28B
EBITDA€ -256.17M€ -367.10M€ 1.38B€ 13.10B€ 15.00B
Net Income€ -1.09B€ -665.30M€ 930.30M€ 9.43B€ 10.29B
Balance Sheet
Cash & Short-Term Investments€ 14.83B€ 16.78B€ 16.55B€ 14.06B€ 2.07B
Total Assets€ 21.98B€ 22.53B€ 23.01B€ 23.28B€ 15.83B
Total Debt€ 267.29M€ 254.20M€ 219.10M€ 212.20M€ 301.50M
Net Debt€ -7.40B€ -9.51B€ -11.44B€ -13.66B€ -1.39B
Total Liabilities€ 2.76B€ 3.12B€ 2.76B€ 3.22B€ 3.94B
Stockholders' Equity€ 19.22B€ 19.41B€ 20.25B€ 20.06B€ 11.89B
Cash Flow
Free Cash Flow€ 269.81M€ -244.60M€ 4.67B€ 13.21B€ 735.70M
Operating Cash Flow€ 438.00M€ 207.70M€ 5.37B€ 13.58B€ 889.70M
Investing Cash Flow€ -2.37B€ -2.08B€ -6.95B€ -35.30M€ -566.10M
Financing Cash Flow€ -50.81M€ -45.90M€ -778.60M€ -1.42B€ 94.20M
Currency in EUR

BioNTech SE Earnings and Revenue History

Income Statement >

BioNTech SE Debt to Assets

Balance Sheet >

BioNTech SE Cash Flow

Cash Flow >

BioNTech SE Forecast EPS vs Actual EPS

Earnings >